Tang Capital Management LLC Ventyx Biosciences, Inc. Transaction History
Tang Capital Management LLC
- $819 Million
- Q2 2024
A detailed history of Tang Capital Management LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 3,100,000 shares of VTYX stock, worth $6.85 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
3,100,000
Previous 3,100,000
-0.0%
Holding current value
$6.85 Million
Previous $17.1 Million
58.0%
% of portfolio
0.87%
Previous 2.08%
Shares
2 transactions
Others Institutions Holding VTYX
# of Institutions
122Shares Held
57.4MCall Options Held
222KPut Options Held
269K-
Deerfield Management Company, L.P. (Series C) New York, NY5.83MShares$12.9 Million0.28% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.76MShares$12.7 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA5.25MShares$11.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$10.5 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.17MShares$7.01 Million0.04% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $125M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...